HomeCompareCORBF vs PEP

CORBF vs PEP: Dividend Comparison 2026

CORBF yields 190.48% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CORBF wins by $90.11M in total portfolio value
10 years
CORBF
CORBF
● Live price
190.48%
Share price
$1.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$90.25M
Annual income
$44,400,251.00
Full CORBF calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — CORBF vs PEP

📍 CORBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCORBFPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CORBF + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CORBF pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CORBF
Annual income on $10K today (after 15% tax)
$16,190.48/yr
After 10yr DRIP, annual income (after tax)
$37,740,213.35/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, CORBF beats the other by $37,687,619.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CORBF + PEP for your $10,000?

CORBF: 50%PEP: 50%
100% PEP50/50100% CORBF
Portfolio after 10yr
$45.20M
Annual income
$22,231,063.34/yr
Blended yield
49.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

CORBF
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
4.7
Piotroski
8/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CORBF buys
0
PEP buys
0
No recent congressional trades found for CORBF or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCORBFPEP
Forward yield190.48%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$90.25M$141.9K
Annual income after 10y$44,400,251.00$61,875.67
Total dividends collected$84.82M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold

Year-by-year: CORBF vs PEP ($10,000, DRIP)

YearCORBF PortfolioCORBF Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$29,748$19,047.62$10,849$509.42+$18.9KCORBF
2$84,785$52,955.26$11,969$750.47+$72.8KCORBF
3$231,777$141,056.55$13,500$1,124.14+$218.3KCORBF
4$608,380$360,378.77$15,680$1,721.66+$592.7KCORBF
5$1,535,024$884,057.33$18,929$2,715.34+$1.52MCORBF
6$3,727,144$2,084,668.10$24,023$4,450.80+$3.70MCORBF
7$8,718,621$4,730,577.40$32,510$7,669.92+$8.69MCORBF
8$19,670,865$10,341,940.93$47,709$14,093.60+$19.62MCORBF
9$42,854,727$21,806,900.51$77,415$28,083.48+$42.78MCORBF
10$90,254,808$44,400,251.00$141,922$61,875.67+$90.11MCORBF

CORBF vs PEP: Complete Analysis 2026

CORBFStock

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Full CORBF Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this CORBF vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CORBF vs SCHDCORBF vs JEPICORBF vs OCORBF vs KOCORBF vs MAINCORBF vs MOCORBF vs PMCORBF vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.